PORTAL VEIN THROMBOSIS THERAPEUTIC AGENT

摘要

[Problem]To provide a novel technique, which is more effective in the treatment of portal vein thrombosis. [Solution] This portal vein thrombosis therapeutic agent contains an antithrombin III as an active ingredient, is administered to patients with portal vein thrombosis in an antithrombin III-administered dosage of 1000-3600 IU/day for 5 days, and is re-administered at an interval of 0-4 days in the same dosage and period.